| Name | Title | Contact Details |
|---|
IVDesk is highly differentiated from other cloud-based providers in part by our focus on SMB organizations instead of enterprise-sized organizations but, more importantly, by the ease-of-use of our cloud-delivered applications and data approach. Transition to our service is quick for all users and our highly reliable system dramatically reduces the high business costs caused by IT downtime.
Computer Management is a Lapeer, MI-based company in the Business Services sector.
Soreal Design is a Kansas City, MO-based company in the Business Services sector.
Focal Point Communications is a Cincinnati, OH-based company in the Business Services sector.
Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Currently, seven candidates are in clinical development internally and with partners that have been engineered with Xencor's XmAb® technology. Xencor's internally-discovered programs include XmAb5871, in Phase 1b/2a clinical trials for the treatment of Rheumatoid arthritis and lupus, XmAb7195 in Phase 1 development for the treatment of asthma, and XmAb5574/MOR208 which has been licensed to Morphosys AG and is in Phase 2 clinical trials for the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma. Xencor's XmAb antibody engineering technology enables small changes to the structure of monoclonal antibodies resulting in new mechanisms of therapeutic action. Xencor partners include Amgen, Merck, Janssen R&D LLC, Alexion and Boehringer Ingelheim.